-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 G+50rlPvGrqquxJDtv8emNBfjLwU5fFDJswlzb22LmvK6x7n1WPT0Jp/Edqi5HcB
 6CCMAhE0NlHzoyRpNSw0tQ==

<SEC-DOCUMENT>0001193125-07-137719.txt : 20070618
<SEC-HEADER>0001193125-07-137719.hdr.sgml : 20070618
<ACCEPTANCE-DATETIME>20070618172335
ACCESSION NUMBER:		0001193125-07-137719
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20070618
DATE AS OF CHANGE:		20070618
EFFECTIVENESS DATE:		20070618

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYO CELL INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000862692
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SERVICES, NEC [8900]
		IRS NUMBER:				223023093
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1130

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23386
		FILM NUMBER:		07926601

	BUSINESS ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
		BUSINESS PHONE:		7277230333

	MAIL ADDRESS:	
		STREET 1:		3165 MCMULLEN BOOTH RD
		STREET 2:		BLDG. B
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33761
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>ddefa14a.htm
<DESCRIPTION>PROXY
<TEXT>
<HTML><HEAD>
<TITLE>Proxy</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="4"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>(RULE 14A-101)
</B></FONT></P> <P STYLE="margin-top:16px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section 14(a) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Filed by the Registrant: <FONT FACE="WINGDINGS">&#120;</FONT>
&nbsp;&nbsp;Filed by a Party other than the Registrant: </FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Check the appropriate box: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Preliminary Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B> </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Definitive Proxy Statement </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><FONT FACE="WINGDINGS">&#120;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Definitive Additional Materials </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12 </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CRYO-CELL INTERNATIONAL, INC. </B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"
ALIGN="left"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate
box): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><FONT FACE="WINGDINGS">&#120;</FONT>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">No fee required. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was
determined): </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(5)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Total fee paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Fee paid previously with preliminary materials. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the form or schedule and the date of its filing. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Amount previously paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Form, schedule or registration statement no.: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Filing party: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Date filed: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE WIDTH="99%">
<TR>
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="92%"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g54631logo1.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>June 18, 2007 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Dear Fellow
Shareholder: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:3px;line-height:95%; vertical-align:top"><FONT FACE="Times New Roman" SIZE="2">The July&nbsp;16</FONT><FONT FACE="Times New Roman" SIZE="1"
COLOR="#000000"><SUP>th</SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> annual meeting is less than a month away. Whether or not you plan to attend the Annual Meeting, your Board of Directors urges you to vote <B><U>FOR</U> your
Board&#146;s nominees today</B>. Your vote is more critical this year than ever before, because the group led by David Portnoy has launched a campaign to take control of your Company without paying you a premium. This campaign is based on distorted
one-sided information and personal attacks. We urge you to consider the whole story. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>The Real Story about Cryo-Cell: Our Strategy of Investing In Our
Business Is Just Starting to Show Its Benefits. </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">In spite of intense industry competition, Cryo-Cell&#146;s revenue increased by 129% from FY03 to FY06 from $7.5 million to $17.2 million. Following nine
consecutive quarters of profitability from Q104 through Q106, in early 2006, your Board made the decision to invest in marketing activities and product diversification. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">Product diversification in the newly emerging stem cell industry requires comprehensive market understanding; technological and regulatory expertise; investment and
time. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">Cryo-Cell&#146;s May 2007 announcement of the Maternal Placental Stem Cell (MPSC) discovery and related intellectual property (IP) was possible, in part, because of
the Board&#146;s decision to invest in the growth of our business. As part of the Company&#146;s long-term strategy, Cryo-Cell&#146;s MPSC technology is expected to create a significant source of potential new revenue for Cryo-Cell.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">In addition, our marketing initiatives, including our award-winning product rebranding, have positioned our core business for future growth. As shown in the table
below, two public company competitors, ViaCell and Cord Blood America, spend a significantly greater percentage of their revenues than Cryo-Cell on Marketing&nbsp;&amp; Sales. </FONT></P></TD></TR></TABLE> <P
STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g54631image004.gif" ALT="LOGO"> </P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Figure 1: Based on SEC (Securities&nbsp;&amp; Exchange Commission) Public Company Filings </B></FONT></P> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">The past two years have been very challenging for our entire industry. For example, in April 2005, regulation of private cord blood banks by the Food and Drug
Administration (FDA) impacted the entire industry with significantly increasing expense for all private cord blood </FONT>
</P></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:0%">
<FONT FACE="Times New Roman" SIZE="2">banks to comply with new regulatory and accreditation standards. During this period, the stock prices of ViaCell and Cord Blood America have shown similar
levels of volatility to that of Cryo-Cell. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">When presented from a balanced industry perspective, these facts depict a very different
picture of Cryo-Cell&#146;s progress than the negative portrayal described by Mr.&nbsp;Portnoy. The current team has remained steadfastly focused on building enterprise value based on our belief that value creation ultimately will drive the price of
your stock over time. At this critical time, just as the benefits to Cryo-Cell are starting to be realized, Mr.&nbsp;Portnoy is asking shareholders to replace the current experienced team with a group of directors with a notable lack of relevant
indicated professional experience and public company experience. <B>This is the wrong move for Cryo-Cell and for the future of your investment. </B> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">This
year the Board has nominated a sixth director, Andrew Filipowski. Mr.&nbsp;Filipowski is an entrepreneur who has founded several businesses over the past 20 years and has been an officer and director of several publicly held companies. In addition,
he owns more than 6% of Cryo-Cell&#146;s outstanding stock and he will bring to the Cryo-Cell boardroom the perspective of a large shareholder. Mr.&nbsp;Filipowski recently expressed his opinion to the media as follows: </FONT></P> <P
STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT FACE="Times New Roman" SIZE="2"><I>&#147;I always had confidence in Cryo-Cell and thought it was one of the best positioned in an industry that should create a lot of value and maybe
even tremendous value; that is why I have bought as much of the company's stock as I have. I actually was frustrated by the fact that the Company was making progress but certain shareholders were naively and with very little substantive experience
in business looking to apply sophomoric gimmicks to spike the stock when the value of this company doing the right thing over time would generate 100 fold increases in value.&#148; &#151; </I><B>Andrew J. Filipowski</B><I> </I></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Please cast your vote today to support the current Cryo-Cell Board of Directors and management team in our efforts to continue your Company&#146;s progress.<B><I> You
may vote by Internet by following the instructions on the enclosed card or by completing, signing, dating and mailing your WHITE Proxy Card in the postage-paid envelope. </I></B><I><U>We urge you NOT to sign or return any gold proxy cards that may
be sent to you by Mr.&nbsp;Portnoy, as that will nullify your vote on the WHITE proxy card. </U></I>If you do return a gold proxy card or have already done so, you can automatically revoke it by signing, dating and returning your WHITE proxy card.
If you need assistance or have any questions, please call Georgeson Inc., which is assisting Cryo-Cell with proxy solicitation, at (888)&nbsp;605-7511. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">On
behalf of your Board of Directors, </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px">

<IMG SRC="g54631image006.gif" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Mercedes Walton </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">Chairman&nbsp;&amp; Chief Executive Officer </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g54631image004.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g54631image004.gif
M1TE&.#EAIP'-`'<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"'Y
M!`$`````+`0`!0">`<,`@@``````````__\``/__S/___P$"`P$"`P/_&+K<
M_C#*2:N]..O-N_]@*(YD5)QHJJYLZ[YP+,]T;=]XKN]\[__`X$HA+!J/R*1R
MR6PZF\2G=$JM6J_8+"VJ[7J_X+#XRAV;S^BT^EQ>N]_PN%S7GMOO^+RYKN_[
M_X!&?(&$A8:'*H-L"RZ*,@Q'=8J,0P$QDY:)CR>.C0V)E"AMH9TO49F799">
M?J5@IZB@.;"Q0*.<+:$II9BR,+`WJ\`%I+BBJK4SEIG)+*/,S9S1<JY?G=7.
MJ-A;R<RYQ+7;W*ETR]W:VL:X7.+KQ,KAT\=_[5B2P^#'TWSLYO/2[\!!JQ2-
M"+M\^3XA-#B0$22#`@4Z'(A0UC-/L1C^TR>M_]N[?0R19:/83]Z8>O;Z)?2F
M<9"DA<)@-O3G*]O"B!)ITMJ9L^/*B3<_GO,),%>\BB(?'@6YDN`N?Q!;F@R#
MDLR]IAI-00.*5>?09P5G%I6*%"K-LJ"RDKU(5";'?RH)FCP[EF[;IQ*;4IMZ
M<JO4B;TZ*J7TB912O!#QZ@7F5?!,M3NY)E:XL2Y<J#`KFW#VT=<JFXYSAN3[
MBC15LYEK5M*7L?%&LHIUB0X*FS'%Q6*SXG1Y%*U;!Z_/\G,76W;QKJOA5*5B
M&W=>W;M8(Y].W;+BZ;7%/G>]%MV\B_B\9XZ;E*NFSHCM#NN^/<YRYH0/$XT_
M$IWVW?:A.VY]N?GZQO^&R<1347?5A0Q8E.'3DW$!5?34;=*%1DN!:[QWAVF(
M5&&A5AF>UB%G'^Z!Q(8AVH)AB2AJ>"(\*79!8HLPQBAC#2_.:..--]:(XXX\
MAJACCT`&"<B/0A9IY%Y')JEDB40NZ>23630)Y9140K%BE5AF"9^67'9IS95>
MABEF#U*.:>:9#J*IYIKEL.GFFS2"">><899)YYU%VHGGGCSJR>>?,_H)Z*`I
M"DKHH1T:BNBBA2C*Z*.MR`GII(7.5=)63A$H*:6<2N%(.@TVF)$H`2W3Z:EI
M5.,-J>J(6FJHJ,;ZI3*P@JJ.J>C)JJN+I)ES"JNW`K3IKL3^X,JJN8[:JE#_
M1I7@[+/01BOMM-16ZZ@-O'!FJZND(@MBL>`&D>T0W`;;[;+GA:LNF7-%1URH
MV^(JS[#KJONI,"6QJHMXC=3K[RST"O+OP'&>1/#!Y(@1,,*H7DMKEADP;(7#
MFT!,P,489ZSQPA)CR[&X6@:@\<@9?]PQBPJ'3/+*)I^<,%4JKSQRRRYSF++%
M,F]<\Q,47Q)SSAC3O#-H,.,,],5"#ZW:2&_A].!K/AM]=-)*5T;NN[C">VZN
MIOP\]1X8'*JJJ_%NG7774@--]0XB'XVTV+V2#:S<7/>;=LYKT^'VVX2.G4[9
MQB2&D;6$%\[`W@08K@'BBC?.X'Z%6_T-W5HO:]?5_UBV[7;>LS!N(^>8CTNY
MLEI[BWF5FG]]DN>!:BAYZ%M77CJZ[F;.NL*WQPAZNM?4GC7IHYJ>+NJYOU)\
MB[O[/B^^]NFKRNNU$[]W\C0>7ZCK!+[BM=I[6(^B:?M>NBVP/?^R/=[=3__Y
MP[\&-3SYU#]LN_JKTR]C:Y\%[VXS_$,?Y?DRBY\RO,<D40C@@`<<'ZQHU[_L
M60.`+$O?YM;'"00F<&X,S-^WRH>V^4VP?A^\GP$MJ,`&ON]6`HR:!U6'._OI
M;H0(+.&WH@<_@]TM@!)DX0LK2,*YG4UX"Q15"LUWPPB"4(<PTH8%!:`L4"DP
MB/S2GK$BIH?4<>^(5Q0AY/_2\K30>%&(*LR+TYIV$"+Z(``#2*,:U\C&`0Q1
M7`2,4AP_),`H$DUVP'L57Q:&QC;Z,8UOM,4<R3#(#-71?US+(_GT6+$S_O&/
M@316(34TR4,<TH$;Y)WO&!E&'O3QD6R,Y!DK.04KHJ]US$$D"MN'1V')CTR@
M;*,HR41*3]62$)=,4R:QMLGH\,99L0REXY[%N&%6H)C&C-SD2JE**);KF?+J
M("R#J<99>O*63C`E#E')3$R>+G:*),Z\;$'-:O9!FT9L80AWV$U=PHZ7BS2;
M-#U93D">$YM0P"<]L.?.X1G&B<_S)@W95D\WWM.%QD,H\OC)0;LYLI[69)L^
MEX#_3I)%-)48[>?_C%70BW9.H5ZHZ,PH:$8'GJ,@S>3G-,OI4<A-8*)*$*G.
MN#G/YS71A`U=YDJIV5)B=!2F29!IR4CZ@$WJKU4X;2D?.[J'GX+414"-4]B8
MH(U0&M67&-R@4LD)T:9"-*J1`*LRF$I545AUD=YAI4-S.D-Z=O4D3EUG0N4:
M4[)2U*QK#,>KS#45.X:4JRSU*DO%6@2A!HUG=HTI7LV)52$21H5L_29!WZJP
MN"(QIAD@["42&]3%VO,ZMO)64FWXT,#"]:M/C81ELTA5SH[(LP;59*T"M\S(
MGI`.K@WI:D\)A=UNL[<0I2(.\F,<)_+.)<W$7]/(^,3;_\XBMR[R;3I;BUJZ
M!E6ZT\460RV%5A_*<X^_P`!TM?!)GFKV%]@=:3;3J][A;K=KH87F=QN9BR7:
MEX3CC1)[A[K>ZE[VNO[][RMYEMSN(G6^G1S"?1=<WF#VM,&Q-"S?@#O8U`IB
MO_QU;T9%]S?O!NYL\U3P@NT+85`^&,,3IFZ%K3LB%*=8NQONJX%;Z<NP6&#$
M).YH,B?@8L7UV'`N3AP%'.JI`@<+<+,+8E83@>,EEOB1)PXP;U5L7@L7-LAR
MRB6'P=E+<8:8R4V.87[MT6/$2OFW5'8PXA)'A_>:L<,'/C`0E[R+,(N9LE0I
M<W]7+&#5GAG-,&ZGZ)Q6C#'ZU?^Y,`SSDR$IV"JSV,]\9BU%L=SF&).VOG9F
MXIC)H&<*.[K/%_YS=FGDYJ(U(M.:QO,K.IWF")_7%)2>!3?\XI$E'YJ\OT#U
MHOT8Y4A/>=*B;F^K3;SF++/OAXUUID`W>NI,[UJ6C5:SE87P[%`"-0.QUK!H
MRD:Z9&GUTL[0]:8GQFI@^QK0PQ5WL(4=:"O*T+M/O#6S,6WG:N<UVJZ>MKC*
MG6YG9SL8HICI`BFSF&_?K-GU'K>&^`W@<X\Z&.IV^,/EY^ZLAA.(\K9'KOVM
M:FLPO,7KSC`=(OYI4+]9X+5>I5IK>'!Z*UKAS/DXI$O^ZWXG/.0B;S?*DUTN
MC*<THR[_;[*]&5M9G+\88!:0^19(+FU]UQ8X^HJS7D<K54QQ45,)!O/-35MT
MB;/;YB\W.IL]R?1\.[VM6J$U!D&,PD#+U\O@-47938QO8I\=X6'WNL!'SG&]
M[]WM!%ZV3I$<S;CC7>@P+Z72E3%W*%^[\9`L=J4%C2&]QAD];$>[UO/.T[H[
M_NY!Q_'0`?GXOM.\YELH]2,>>_F&#%C$6^\\S\0K]F$%`/*\+GWLF_[HK)=5
M\+`CO"9^60'<R])PJ$ZUWX,6`N-;>WK--SWOIS;D9C7NY^02OCR)'&[I1YAG
MR1^]&W7/^>FC'EO.SZOD[8"2WW49\U^NL_=-/%6VA7_QCTA__S7)CWBQCWT.
MVP!G-.9EW`=[Y6=VO9=_^D=ZH-=]NX>`D@9V_;=\A\5^)_)/S@,\[2)W\_=Y
M#;AY!VAW":B`#RB")D>"(>B!([@(X&:`$WAZZ(9^"SA^'PB"HH=_ES"#$G9T
M;V!;`V6#(R9^._A_LW!_M4<F.LA_-^A_/;5Z+0B$#/9O$OB"YA>#,EB"*AB!
M$->!D?=JV;15'(B%75B#B9:"8WB".<B%N4>&9;B$%,B#;N"#=-:&02B%6ZB&
MLJ2$=7B$9(>'S\>&40*&A^>&,#AQ2Y>$@$@,B+B"&R>&:YB(5O&$\N>(>0A3
MM[>(:-B(9OB(F1B&FUB)D#@Q@AAZ>__XAD0XA818A89XB)3XAYTXB*58B!9U
M(:/H@)_HBJ]HB[>H?HEXB:W(BXSHB50(@5H8A[7H@JE(C.?'BK^X?[V(B<5(
M(]`8C6H@A[0SB;OHC(#HB\W(@,$(BU'(A_;GA\#XC1["-O?`+S(FC,EH@KF(
MC.V8A<O(C,/HCO/(>.2HC>98&FSC8?!G>*08CJ:X*=R8C=[XCO`HD++X=ZBH
MD*JXBJDB*<+'$O2EB_%XA@B)C09)@_N8D/<EA'KHD,IHA14BD?Y8>!7ID3G&
MA'V8CP=)C?C8C1R9D1IYD9Q(D^1EDJWG2BD)A1]IAU<HDSMH>]-(DO1HDZ#8
MD2&EDP.X#C;_MF-0&952.94[QH*3%T[P5X#4<$Y5U)5@TX\[N7TZQ7Y<F0=-
MF'I?>97O%TU:Z1YEB0=G^7JS@HX`I8$EU3=>N2;66#4,LY=\>3!^^9<#$YB"
MZ2^$69CK<IB(&2Z*N9C%TIB.N2N0&9FR,IG!D"]M\3BBV#P%<E$8F)F:J2*<
M26B6"3"&((#NUUP;-CK8!P5<9ERFEII<A@BEZ5ZHB6ADP)K`EYNWJ61_=9MQ
M*2[!22:Z.8>\.9N9YR*L&9>R^2Z),IR>5)Q[V9R<E#+`&9H:!YP:10_066F]
M:9S8TYO)N5':>8T:MYQSQIVT.6.6]U=')I8/])Z6$YNO"9Y5U)W:E/:=YLE0
MK_D9[EF<^\F?O*2:D6))5P5/RLF>/WB>\NEM\=F@[D>;^%EU5D>:UJ00GVF?
MGL(\S!51&(J98W2:$TJ9G5*;)$HI)GJBD)*B*LHH+-JBB/*B,-HW(SJCBR*C
M-OHG.)JC>[*C/'HG/OJC<Q*D0OHF1%JD;'*D2*HF2KJD9]*D3CHF5#FE5%JE
*5GJE6/H!"0``.S\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g54631image006.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g54631image006.gif
M1TE&.#EAI``U`'<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"'Y
M!`$`````+`````"D`#4`AP```````!H:&AD9&145%1\?'QP<'!T='1X>'CX^
M/CL[.SHZ.BHJ*C<W-S$Q,34U-3T]/2<G)S,S,S`P,"DI*3@X.#P\/"PL+#DY
M.30T-",C(S(R,C\_/R\O+R(B(BLK*R8F)B$A(2`@("XN+B@H*#8V-BTM+24E
M)4Y.3DE)24A(2%=75T-#0U%144]/3TQ,3%U=75]?7T%!04I*2D5%155554U-
M35-34T='1T1$1$M+2U)24E!04%965EQ<7$!`0%M;6U145%E965I:6D)"0EY>
M7D9&1EA86'EY>7Y^?G!P<'AX>'Q\?&%A87-S<W)R<FYN;FQL;&-C8V=G9VMK
M:WIZ>FUM;6IJ:G1T=&EI:7U]?7%Q<6)B8F5E97=W=V]O;VAH:&1D9'5U=6!@
M8'9V=G]_?V9F9GM[>Y.3DX.#@XZ.CHR,C)>7EX&!@8V-C965E8B(B(^/CXJ*
MBH"`@(*"@I24E):6EH>'AX2$A)^?GX6%A8F)B9N;FYR<G)J:FIB8F(:&AI&1
MD8N+BYZ>GI"0D)*2DIF9F9V=G;R\O+JZNJVMK;>WMZJJJK.SL["PL*NKJ[&Q
ML:.CH[Z^OK*RLKBXN*:FIJ"@H+6UM:&AH;N[NZRLK*6EI:ZNKJ>GI[FYN:FI
MJ;^_OZ^OKZ*BHK:VMJ2DI+V]O;2TM*BHJ,3$Q,7%Q=G9V=+2TM_?W]75U<'!
MP=;6UM'1T=K:VMO;V]W=W<_/S][>WMC8V-34U,;&QLO+R\+"PM/3T\?'Q\K*
MRL/#P\C(R,S,S-?7U\W-S<G)R<[.SL#`P-S<W-#0T.[N[O?W]_O[^_/S\_GY
M^?7U]?CX^/;V]OW]_?'Q\>CHZ.+BXNOKZ_S\_.KJZO[^_N'AX?3T].3DY._O
M[^#@X/+R\N;FYOKZ^N/CX_#P\.7EY>WM[>?GY^SL[.GIZ?___P$"`P$"`P$"
M`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"`P$"
M`P$"`P$"`P$"`P$"`P$"`P$"`PC_``$('$AP8#(`!P4R`]#,(`!E#AL61$AQ
M8<*!"P5"G,B1XT6(&3N*''EN9,&+'0^B-"EPI4AG(ID]@TG0HD>6.'/JW`D@
MI$N1/WF.7.B38D.5%2G"/+BTI].%$IT*7$;Q8D.(1Y,>S-K2:4.B3DN61`KQ
M8,B-3LU6I:A1*L.W!ZG6'%CVK4*M`*+EO+C2V;.HSP0^"TEX8-2047=>1(QQ
M8,EI,86RQ1E49\C&;;?"?;BVKDVU-AL&OHLT*^//:9\"&,T9Z<)E:)`D20.@
M)%6RG`FJ=>UVL5.T1=$*A-FTZU4`MUD&1KTPL#.:-KM6ONQ68.*;.Y4D2J5F
MB1IJ!:FS_Y0;7N?*9Y4G?N3<T+33Y,GBUYY?VFE3FV#K6I^,=#U2W6NM@HA8
M`*S!1"N]M497:OBEIIEF$#5U$#*<U27A2:N-Q)=#2/U5#0#6N*+((L]<LV%7
M=TEF&&;5.230AP*5M(82V&"8$G:3*<:B3FAMB!I2);'1!`HI)."$-K^I!E9_
M:_VW65=0X>7;@YQ!`T`;3U"I%DQ%G>C@6J2Y]6-NC35')D<EV1281,Z<\PH4
M*J2!2"IN*!#%-LXD-%..+HH4%4K)'/;29%&6)`4`5DYTG8KIV;@3>0<QLM:2
M\ZV`!"RUG7,.'`LL,E:&]ZG&VT$])G57=&^-R5QMCQP:(7))+?\$TEMUS:H9
M@$QF1:5G*[J4T#6Q*,`"9WEFE,PYD+3PA%XP!0:+"VHX^`QK-+6(HEUB<L05
M4)/),H4K&6K8YUPI3K:HM3E%,I]8:QB0Q$(P?6KE"W$`YQ05,(SZI:!A0EEA
MK!1!A!5%WWRIEAQ5U%7?<0PGI:MJU]I:7K\K`A`#`R\`\(HJB+31@`RJ]'0.
MQ]U\4XTW5LR1S3>!J93,,E=<$4VU#5;&9*/73C0+%I3T"1$TM&3!BI4-`C@7
MI>*99/-(,SCP0)$0+!`!'0\I4TD+$M1A91LQU'(-<6M9044W1G&8*D7+I7:<
M3:&N9-,Y=@B@Q349/NS,%HYD>/.D`+3_'7!J^V65W%>3\0I1RP#8LL@=6^`!
M21X).'*-,FPH(`4-+@!P2PV+(,2,2M,RTXP67*26=J#5#I3G</"R-5A2:5^[
M4#7<V/`"+=\D%-^>`LFA1TGE_JD03<D@?M`K6]`"9F/"%<3E0.1-1F!)>]S@
M#0"*X&`)`'+D@,L>60!0,),P6:%:>V4SB;3>:B<5*EARX`#)>WB5A$7?]IU/
M49KX(]4-%1.X1$D>%A<E-48SJ#E.0;8!`SF<8Q$NP$0USI$)"-3A!IDXAWR(
MDR=E8&,%:`!`-DPE'_2PS6P/RM,&,\2:E;1"!T^HA@H9A#\[*,$:SD!5"\\A
M#2^PX1D%:\HW_^S0`"Z$@S^>$PUE%L00E"RD)"W(12YVD(=S%$P2+."!%1"W
M)J=`0Q<N2,2GGK>WSSG'80K:3?L(5XTW]```'SI(23X$DX:4Q`?BVPREN&$%
M"M``24RI#21^\`5%G(-P4;+)JR!"E;4E"56-T0,5Q`$&)"1#8+Y@@00T8:)O
MY*E93MD$$,#Q#3,FXSF@X\U,JN4EUA2E;ZPY!R5RT`@3G1(:L*C#.#R)N%KP
MX!?0<!)3KL&-%:@`"C$(1_%R.+(@8,$2X0BB?,1U%_0)Q$I!:8@VPA`)/@0A
M%I_BA`)>P(V"*1%QV1`#$O)X(<0UR'A*F8^9WLF^#P%A#`<)#$2$,/\!2<2S
M8#>0A(D2B;]L*,$&NY##&NBFJ4/B00A]$.BZ$$4L*;'P;WN;"".$X(H>L$&#
M,KD&(BI`AG.([CD&<48U6"$$3@1S=[L[HY.:@9[7,>58R%A%3WB''H>`L@\V
M\(4&3WD-/S#``JVHQBD1\HU9I"`1)L)?RXY5"0L@0AI<`,8YR"&)/]"!"Q>P
M``:Z8`4GP($-B0B&.`8XD);)A#-1`EOPRN6%*C#A"N5X2YL<D8%.]$T^2)D@
M)F!`2J0T!7%9N9`BP[&$'"BO*0-KW4&"L0)`*`4:N:!!!H9`H><5C`64H)M,
M50J`&[0!;D9$`P\JL``<:*`&7-##'*8P!BG_U$`%+PB"%X2!%X+.BE>OF4@L
MFA`('BA",'*TA`QZH=3XY).IW1@#$Y3:-[\`MGA*62IZJA48(`IB`H"01I=<
M9Y8O<`$;T##A,YB`@P0$`AH22<9";*$"3RBC&<="R#.@\8T[`($:L4!!)9Y!
MA19L0A9NX$$C.*&I;W2C'-H0QAN>,`,Z`"^'^#.(;_SB*#D"0`A4@,*7F."#
M:%Y(CL!H`:).R6&5?*XJG^/P"0^B"QF4`1IQY%L=:R.)&7RB)#"IQC"(4`05
MT$*T^(,&*(SP"V5\XQS0L%)@;D&#4)SC"D7HAC*0L8US8(,';MC$?*P$90(-
MXRWND0Y[)D,5UC@%_PLJP($NV'J0<71A"S)$B'.+E8PJB*$94>ZI,W('T]4=
M"Y7/^8N>J]$&%-3B'*_S2\$$@S]FA$,(7UCE<YQ!API@8`V?6R9"SK$&%MCB
M'-E0A!4&,9-KL$$'TA!%`GY1#1Q_C0DPP`0D/M0,9FR#&)MND[FF:3;U"&2$
M=XG%#B2P!27"!!JJR,$?Z.9<A.2I&L6PP9R748Y03_!S]Y5/P92Z%$,GHQK@
M:$$2/J2,:Y2DNZ8#P"AHX`M0?<,8-MB`$,BQFCT-QAE=D$(U9&$%!PR``]NH
M1C.F@(1)6``-RHC/0F@A`S)@XAG*6`X@;#"+DG@R/^S3$MKBF9AS<((%.?_8
M=K^_<8U!R$!RI_,<-)3P!&A,0PE"D,4WO@$+2(1#&7YAQG-D8NYI.4,9FB(%
M!X91ZV@,P@[+0"4VBZ<,9C#!"[UVS"`Z,(-?G$.%-&T3)7Z@"V"HP`@U(,`&
MIG$-<K@`"2FHPJ#ERPQH$$("5:!&-0)SCCAXH`"%:'`@-]T2ZK30*STA3TFT
MT`$Z>+(JWXC&&%2@H+2=PQ4O2(4YNF``":QB@E6@P#`T^.0&(TI3*H2&26=!
M#C.`H1O50$85/@""4E3C&U8"R3.J\0H=F(*MYZA%#RP`KJ9<&P`RB`(B6%"$
M4J@@`#A`QCF.H0`*4,$:V#09-G0@!'">\ARI($+_"CK@`#\\.D.2C6<@$;@9
MQ`%@&BX@`BZ`1Y%K@,("KY?)G@YR#7,<X0[.L`0?X`%DP`S*L`TK4'LX=@ZX
M,`5S8`XFM0JT,"W0D`V;(`45,`,5(`K7\`U[(`$_(`-)=0Z=P`6[0&[?0`<P
M0"''<@ZE<`,74`7G\"&AY@S!)`8_P`@I$`760`<A@`)B=`YH<`%?@`T:9(/G
MH`R&L`"CEPRJEPM!@`.M<`FT1P1B$`SNUE#*`'3Q-AR]=7@.D`:SLA3GH`8;
ML`?4!3;)D`UGT`/F4`P+D`$8D`M1]@L9(`)_<`[6(`@C$``'``OB@`0.8`-#
M8PY:``(<$`83H`"T,'T)_\`%.I`%N\<(%:`!H043OA1XJB<-=T`#3<`!BO`U
MH',.T9`$"J`(6W`$M6`'&J`#XW`.LX`''<`#UO!U+'<.PQ`%$E`#+2@.F/`#
M'I"'P_`#;Y`&"5`#K&`,Q``+K+`-'J8I[%9I7S)"&[$$%E!O$F)I0V`$P"!:
M67<LGH`!DW`.3/`!'P`'GG0-A'`!&H`$S$`'!U`$4*`&L@`$)"`"$,`-VP`%
M!:`$P3`.,5`$SW`.;S`!/,`!Q``-G5`"(9`"W+"%U4`+/^`*Y[`,E[`#/[`)
MT0`#>0`-9=$FU.`%#5`)JE`!4W`%((``.%`*?I`"$*`",=`,#:4*<)`"4*`#
M,__P"JV0!RWP`U#0`7(0!PF0)><P!Q0P`QL@`3+``C``!7"`!J<P#*Q`#='P
M9!.5>UO(&H;``TY0>0!`-Q+0!./P%@.Y>]K0`EZ0#-&P`@40`Z0$#:-0`F*@
M`&?`"!>`!]'0;G9``4A@!(/P#6O0`760#>=@##+@!IJ"!06P`7W0"F(``5SP
M`&)P2DZ8"AN0!GF`D5VP"YJ"!U_P9!]R#KT0`QS`8*\P`2"0`H[P!AE0`AGP
M!<I#!)Y@#(A0!48`!*,`#7Y``0OP`T2P!<=@#D!P`0XP!0_Y#4]@`!3``U*0
M!#!P`T`P`T;P`QS``CT0!&-0!GW`";B`#=@0#0U!-]3_M@T]``&G0!#.H0QZ
M8`*!5SSQD4//(`8HP`KG8`XJL`#"H"FI4`%1``F":092$`ZVE@4-X`)MD`S!
M\`-G\'6I``8:8`C?``Q&@``JX`35N0F:T`!^$$PY-`M'X`!$,`60().XAPHY
M@`GD8`Z\0`8ED`("%7MV$`G38%*@D`BX`))<8`$_T``[<`CDD(3FD`=VH`G$
M\&3*4`R:L`O"I@THL`";L`P3!&7AP`KR)@J'(%M-,`,Z<`-!<`-$L`)9$`5*
MX`1^@&P<<`3<T"0@T@(R$`O08&A?F0<*\'O=L`0%@`+6,`Z=\`-%H`UR,`&>
M@`-[H"G0T`I!X`$/,`G=\`D3_X`)I@`&1T`(*!<&,@`!Q-D"@:`*E[``'0`*
M4O80NT`(`-`-2=@3U=`-4^``.K`#%:`"AF`,7T=1_$,@NW<+`%`(I@"!HI@I
MIL=W)M43R``'M8%C7K0NF@(`%.(*Q;`]6H`$,"`$-:`#'2`*YW`$+B`'-I()
M#O`%$><RYS`*,H`']1D%&5!P'$`##N`$U&`-/\`%Y&`#+?`+D.`$(5@!&?`$
MY%`*#/`!_+D*YY`(7``#<5`+OL`+XW`-UZ`+35"FV/6,$8=<WQ`.CU`&2=`(
M/_JF@=(W#SMCJG>L,R1Q371*Z'%33X12?R489S%1F8(0W3`+0L`'`+`!;3`?
M#R,''/\P"AJ4(==P"S90!L^022,0"L]@!RDP!9,@D[E@`IMP#I5P`1G0`#90
M!\!`#+Y@#M<0#I80"+B`=,QP#=U`-@TE0QB7#$@6<3'W7$XH%C/8/QB576`S
MLA=%/FBF9V8"2HBE5P;T,P`P"P]1!+_P$]4@"970#83W#7;6`VL5""?P"#-8
M#=1P+,S`#-2@".;`,I+P"*4@#E$F>*67A#)1=WFF$KD#1RCUGJ934[?B7)3I
M$&;$5*.R0L6#7T>1$,Z`7VSK,AO")*Q!.%^9$9_B'A]2,$!T+$2;"R8E#:I0
M=?)5#=?`#"9S+*64A:>7:-@E0W.W5$K4$&"C1!VB?DLE1(#_I2#:RS>!1"F:
ML6--D;VW:U$P42M\DB!>J$*BJ0*,<`TR-$%^,2W)X$GXA7$CVRPC.WA[QF+Q
M41;-@$H]@6$J<<##L6>LM!JK<[=>HCNY^[_IHSIMU2>^(3L=41@U@Q#00`X]
M0#61*[QZ(U^I,KJ@M+UQ:U$RE6>M@S[M!#OHIZ9A`F\P,4)JJ*:(=#;C"Q8/
M,R;(UA'H$[DM@P4JID$M4[HFY%S7,"TMLTJ!,KM'873/M1HT%3K;12H99F@H
M)72Z\SS;,A(]?"V&%1&.DC0F(3PKH18-`0V-L`"&I&>#AS]S=U%P"V]HJWYJ
M&A_]*U5K84*@DEWHLV&L6S;I9R:$_Y-8\:8OH2&^9=,\?=(Z97`#Z)5*+:$2
M*K04`0S!N`MT'+8?\L4EV'M)X7NRB;8BJ'3*&-+&+@)8K[,?GN-3Z"(\<Y4S
MN**F5@(.>11(W87"^G)B%$&#?9P_9G)&._9<AZ6F$D-`F[$W69$V,F4PL$)/
MNEM1(]%3[OF5L<K)G[3*@T&9"+P[?X6Z^30M5<'*>?(7ROQ7-T4<2^6%N&QL
MJ^$C&08Q9,DB8*$>;M82J>,GU'Q&=:NF9XL_W)L:?J/(^K5^!,W'ZL,GVY*[
M9Z-&^Y%`A$(_,[46T2,N+-88M2L:@"5C'&9=L+040B<8Q.,R=>%*]7P1S8)=
M=!PHS1//LO',+<52>&O,MJNAQF:3*!Q,$&QLT,_,QS''11=<Q'53S'L32%EQ
MT`O386CL6V8S*XML4>6B,`5Q+FYQ>/]!;#.AR0VS.R@5&"-TQFKA3G1K+B/G
M&M6V(^'B*`"B'\ZCP6ZAU3B2$1A'Q!?]P85LQR,GS`7]P6!!%/*QTHBG)E]B
MOGC1$,D!<O4A*TI]V'!UR$ZRT=RRT^%ALJN3.\;GR9G<$RA\%UVDOPFLR8=G
M'`7!SMCRSP"2-!O\UH6A%C7]VG@M*++=$8VT%HS\7-,\OOJB1N5+)ER\U!1U
:'?`D<AOR/./5%Y1-$51!'J\TU%XBRP$!`#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g54631logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g54631logo1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`,@"M`P$1``(1`0,1`?_$`,L```$%`0$``P``````
M``````D`!@<("@4$`0(#`0`"`P$!`0$`````````````!@,$!0(!!PD0```&
M`0(#`P8'"0L-`0````$"`P0%!@<`"!$2"2$3%!46-C<X.3$B-&0U9AA!43)C
M5656%WA2(U,D="6V9[=H&6%QH6(S0T14U);6=Y<*$0`!`@0#!00$"@@&`P$`
M```!`@,`$00%(3$&05%A$A-Q@9$BH<$R%+'10E*R(S,5%C:2HC1TA$8'".%B
M@F,E-?)#&`G_V@`,`P$``A$#$0`_`-E&]_>G0-E6*_/2RH!8KG8E7<5CBA-W
M96CNSS+9`JSER\="14T96H1-4BC]YR'[L#D3(4RRJ91TK9;7;D_TT8-C%2MP
M]9.P1DW>[,6BFZKGF=5@E.\^H#:>[,P*JE[6.H;U"XQ#)>YW/LWM\Q-:4@DZ
MOB>H1SQ@^7A7("K'K*4YM)Q2,:R<-S@**\Z[D9-5,0.=`A3%X[KM=:+0KHT3
M0=J$X%9,\>W']4`<86V;;?+ZGWBX/EBF5BE"1C+9Y9B0W<Q)X0]ENA15*ZF$
MQBS=-EVFWAH45H^?<1D,=`'A`YTQ4&MKU>80(=<.(F3=B8H#QX&$.V(:H<7Y
M7V&U-;IGUS'HB8Z-:1YJ:I=0]L,AZI'TPQ:AO*W@=.S,-=PGOS>'RMABU+=S
M5<WM@5D9-C&I.$VZ\ZRG@:-7UF8PPN4S2T7)I#,LTCE61563[LJ\KENM]XIU
M5-J'3J4YH]4MD]A&!R[(&KK=+%5)I+U];2*R<S,M\\S+Y0/F&8)VZ'H^08RS
M!E*1CQM(1LDT;2$>_9+)N6;YB\1(X:/&CA$QTG#9RW4*=,Y1$IRF`0'@.E$@
MI)2H24##TE04D*29I(F#'KUY'L+1!"T00M$$+1!"T00M$$<.S6:`IE=G+=:Y
M=C`5FM13^<GYN37*VCXJ(C&RCQ^_=KF[$T&S9(QC#VCP#L`1[-=(0MQ8;;!*
MU&0`VDQPXXAILNN$);2"23D`,S&?"4W7;V>I9DJS8[V4.7&"=OE5>^`L.8I(
M%8J>?MU?D[F2G$F[J2BY"6;AW[.#ABD?D0.!WCI,AN!&T4%LLS*7KE];5J&"
M!B.X9&6U2L-PA'5<KOJ"H4Q:/J:%)D5G`GM.8)V)3C+,P_DNA-3I\AI7)FZ7
M+]PN;HH*O9Y**@TDC/#ASJ'3"PKVB65(5<>("=YS&X<>P1[(OQ0XCRLL-I;W
M3/JD/1$XT:TOS5%2ZMT[9#US/IB+\BX/Z@W3'C!RI@_.$IN)V_5@Q7EQH%Q8
MR#T\!!I'3,[>2=87D)59G"II!P6DX!ZU7:%`55FX(%.8)V:JTWM70JF@S5JR
M4-IX'#'@H&>PSBM44=\T\GWFC>+]"GVDJG@.(F<.*2"-HE!D]GF[*@[QL/1N
M4:6FI$2+=R:"O%,>.4G,I3+6V017=1;A9,J97L>Z07(X8O"D(1TU4*;E(H"B
M2:Y<:!VW5!8<Q3FD["-_QC88:[5<V+K2BI9P5DI.U*MW9M!VB+5:HQI0M$$+
M1!`+-EN6\IVGJI[U\>V7(UUL%#JK+(9JS39BQRDA6:^9ED2F,F9H:%<N5&$>
M9JS=*))BD0O(FH8H=@CIHN5.PW8J9U"$AU13,@"9\IS,)MHJ:ES4E8PXXM3*
M0J2220/,G(;(J,GG[.@]7YWC4<PY*''9=U,=7RT;SQG/-0L">!E%CPP07C/)
MX1AE4RF%'D[L3``\-7_=*7\/=?IHZW0GS2$YSSGOC,%;6?BDT_5<Z'O('+S'
MEE(X2RE$G1L*COXZP=P3MY$YW#VT]HY180+D2.8=ZK0I)E&-&BR!R';.4I[*
M,DX?N"&`0<LXXJ)^)"\`A*C:M/)+>%14;=OFQ]"1+@3.+"4"]ZI5U?-2TPP&
MSRF0\5DD[P)1H^TG0^PM$$4QWZ;4DMX>WFP8K8+P45=V\G#67'EEL)701U?L
MD6]3*NJ[6CVCZ138RD"N\9+@DF<1*X`1*/*'#2M5?]W5@?,RU(A0&T'XC(QD
MWJVBZT*J82#P(*2<@1V8R(F.^*86[.N9^F#M<VCXMO4-2<T7"4NR^'W<U'V2
MQ1D4QJZ#UPXJSEDL_K_E%Z\B:^Y;LS)*(I$X-PY3B';K2;I::]UU0^T5--A/
M/*0)GMV[3CWQDN5E7IZW4M,\$.NE?),$@`;,Q/`2'=#TW5]4V$Q'DYYM^V]8
MGLFY7.<8H=I8(6KA(*5^JR1.3O8AXK!1<Y,S<VRY@!VW;()H,S"!%G)%@.D6
M*@L2ZA@5=6XEFE.1.9&_$@`;IY[!$URU&BEJ#0T+2JBL&8$Y`[L`23O`RVF<
M1C9.IKN,PE!;:K1N8VQQ>-H'-=VLM5NBB\K9(2;QTU@+8RC0D#P,NP>G>@\J
M$FG+(]ZNAWY6[@H%+R<=3(LM'4J>11/E:VD@IR(5,3S'$2\(K.:AKZ-%.Y<*
M<-H>60K$@HDJ61'S3/,9&#:)J$5(15(Y%$E"%4343,!R*$.`&(<ARB)3$,4>
M("'8(:6H;\\1E#:N]OA,?4RV7RRN2LJ]3*W-VF<=&$H=Q$P$:YE'Z@<P@`G*
MU:FY0^Z;@'W==MMJ=<2TC%:B`.TX1&\ZAAI3SADVA))[`)F!5X;ZJT'+;7;;
MNIW!TF.Q74PO3VBXHJM;FW5GN&4).*8).I-*)82+&%1*9L[<"@HKS@T;^%<'
M65(4I>.[4V)2:Y-#2*+CG+S*)$@D$X3S^/$2$+=+J1"K<JY5R`VUSE*$@S4L
M@8R!E\0D9F(<J^^3JA[CV?GMMKV9TF`Q<^$SBN363YA8KR?CQ,)4G3*1F;9C
MUI*(*`7B"K)DJV$>(%6.`<=67+98Z,]*MJ5%\9A(R/8`KTF?"*C=XU%7CJV^
MD0FF.16<QP)4F?<)<8[%7ZJF9<(9#A,;=0K;<ZPBC8E>XBLGT[Q\A4@*F8B2
MT@X8*/;"VE8ELHH4SM>+E':[0@\QVO+VARY8J:J9+UH>ZLLTG/U2.Z8$]\=M
MZDJZ-\4]\IRR%9+3BGUS&\@F6Z.'UM\_O4L*X=P9CB60DS;BYQ*<>.(9Z1PA
M8:1`FA5H"/;.6ISHNXJU6F>CE2G()B+)-!#B)3CQZTU2#WERJ>$NB)8[%&<^
M\`'QCC5]:KW1JCIS/KJGAM2)2[B2.V4%<VJ;?ZWMBP-CW#M<:MTSUV$;+6>2
M1(0%K'=9%%-U:[$\5*4IW"TE+G4[L3"84FQ$DBCR)E`,&OJUUM4NH7M.`W#8
M/#TPRVVA;MU$W2M_)&)WJ.9[SZ)"+#ZJ1>CSNVC5^U<L7S9!XR>MUFCQFZ13
M<-7;5RF9%PV<H*E.DN@NB<2G(8!*8HB`AP'7H)!F,"(\("@4JQ!@4NQ/8'DW
M9IG_`#W96=VI<A@')Y'Y:E28MS8C6>$&.M2TE1U)=![#MH4586LRCU@J=%RH
M8W,GPY@`>&[=+JQ<:1I!2H5:,R92,QYI8SQ(!RA:LUDJ+37/N!:#0N3Y4B<Q
M)4TSPE@"1G'1WB]36#P+D)GM\P?CJ4W";CI,[5J-,@%'9HBLOWZ)73&.F5(E
MI(2LK/+,S`N:.9IE%!N8%'"Z`"4#>6ZRJJF35U2PS1C:<SQ$\`.)VY`QU==0
MHHGQ0T;9?KS\D9`[`93).V0V9D1`CS<WUG:W&&O,[LPQ3+UE)/QSJJ5]^=Y;
MTF(@*ADD8V*RE-SIGB20?@$9.50'_=&'XNK0HM.+5TD5+@7O.7CR@>D12-PU
M8VGK+I&BWGR@^;P"R?0>R+K;(]_V--YT3.1D?$2..LNTH@#><5V%<JTG'(E<
M^!4F(1X+=DI,0B<@'AUA.W;NF3D02<(IB=(RF;<[2];5!1(73J]E0R[#N/H.
MPQKVB]T]V2I*06ZI'M(.8V3&\3PR!!S$#@V'^^"W[?R')O\`:=1=;-T_+U+V
MI^B8P++^::WL7]-,4L3]]H]_;`C/Z.RVM'^6?X?UB,D?F\_O0^`Q;_HJ\%MP
MV^MU*]MC-.P0+F7'B[Y%;UDT\D`B(`<0%Z1+G[`^,`:S]2?LE*$^Q(_13&KI
M+&NK"KVYCZ2XT4Z4(>H6B"%H@@!?7M=OH_&6VB0C#J)RC#+\T]C%$>'?)R32
MK'<,%$N8#%[TCM,@EX@(<P!IKTJ`7GPKV2V)]DX2M:$IIZ=2?:#IEVRP@ENR
M;:K4]KN'H2+28MY#*EP9-[5F7(#Q,CBR7&^3A?*TZ9]+*\[M6*C9)VJBS0YP
M3(F7O!**RBISXMSKW*ZH*B9,),D)V!(P&&\[88+1;6K=2A($ZE8FXK:I1Q..
MX'(>N<,?J;;>/M';0,EUR.8`^N-):!DZC$*0#.%9VG-W3M[%M^!3*&4L%:5?
M,"D#\)1R0?N!J6RUGN=P0M1DVKRJ[#M[C(Q#J&A]_M3C:1-U`YT]J=G>)COC
MF]+;<']H;9UC>4DG_C;ACI`<5W,ZAP%TK(5!LU0A9-P`B*ACS53<,'1SF#XZ
MRBGPB`Z]OE)[I<5A(DVOS#OS'<9B.=.5WOUJ;4HS=;\BNU.1[TR/;$)]9S,4
ME3=LD1A6I=ZYOFY2[1&/8F,:\1>/*^S>,I&P)(`0>\X2;\\=%F``X&)(B&K.
MG*=+E::ES[)E)43QR'AB>Z*FK*I35O%(U]M4+"0-LLSXX#O@:]"V^0N:^H-A
MW9I-B6;PCLEQ=&L[-"%%0T39K-#1L):\FOWC<QBE.%]S!;D6[X1X&5C6@)=F
MMIVK536ERXIPJJE9D=H!F$_HH$QQ,+[-"BKOC5I7C1T;8F-A(`4L_P"I:I'@
M)1J?;MV[1N@T:((MFK9%)NV;-TB(MV[=$A4T4$$4RE32123*!2E*`%*4```X
M:1223,YQ]'``$A@!%9=X^!:1N.V[Y)QS=D621%*])359L#I$#KU"X0[%R[KU
ME9*E34<(F9/2@1<J7QG#115`>)5#`-&Z:LM^A;35ZONZRW9[=2NU%01B>BT@
MN.`"8FKE2>43Q5*.%V)S4JD61A(55U#B4-SV.*,D&>P3./"<!*K>QB;6J&U^
MYWZZ6JTQNV-_#>1G*3.-\EOJZQR"CD!Y64XUT47ODMJZ!1HQ5.Z[U-F5(HDY
M4RD#\\F__P!!?ZPNT-1_5)K0=&/Z&.OE*E"I>^\@Q[/7Y_V<N\GG+73"29I"
MA/FC[*/[<=*I<I=-/W]Y6MF$`@=-'NQ5/GZ?++J<O-Y0KFF!C(RY8TCQ<DTF
M(V/EF"O?,9-DV?LU>'#O&SM$BZ)Q#MX"9-0.(?<'7Z":?OEMU/8J/4EF<ZMI
MKZ5JH97\YIY"7$&6PE*A,;#A'RBNHZBW5KMOJT\M4PXIM8W*02E0\1'NUKQ5
MA:((C+-.0D<2X@RCE!PFFLGCW']NN0(*B()N5J[!/I1NU,(<!X.G#8J?9V_&
MU/3,^\5#;`^6L#Q,HKU;XI:5RI/_`*T*5X`F`J=&&E4H*9DW=ME6SUI]FK,5
M]M#!*:LDU%IS4=`-'Q75B=-0>NR.&B]MMSER=R;E`3MV;8I1Y`$!9-1NN]1%
MO82H4S:!@`93V>`E+M,*.DV6>DY<ZE235NK(F2)@3QS^<K/@!!Q_UBX^_3JG
M?]SPG_7:6.B[\U7@8<>NQ\]'B(`5OD<4W;-U#MIV['%,U`(H97LWF9F*/J\G
M'N$9?^<8&MSTM)M8]95,J\]4[20RASE`%7D2DN/%;F,+7:PY6VA^@?!FVF:)
MC+`D`=A'@2(2KP6K??::YTQ3)Q7*X`<\0"3+>D^*0<XZ.P_WP6_;^0Y-_M.H
MNO+I^7J7M3]$Q[9?S36]B_IIBEB?OM'O[8$9_1V6UH_RS_#^L1DC\WG]Z'P&
M+7XXE4-CG6*R55K:*<%C/=6@X7K4NYYFT2F[OTHC9*TJ593E2*1GD-C)01C"
M/!(SLAC"!1XZH/)^\].H6WB^QF-OE$C^K)7=&FPL6?53C3OEIZG([/,9C]::
M>^-'.D^'R%H@BAW4ISXGMZV?Y6LS&>7@+I:HDV/,=N8]XJPF`MMN(HP3?1#I
MLHFZ;.X"(\7)=\F8ID@:<P"`\-:MFI#5W!M!$VTGF5ND-_:9#OC%O];[C:W7
M`KE=4.5,L^96$QV"9[HS_P"Y>(R:VZ?&PJPY>M=PN-PR+GBS9!,^O4W+V";:
MUVQ,@"J,1>SCET\(R4K3-JZ32`P$+XD1`.(CQ:Z-3!NU4BF2E+:&@GR@`3&>
M7&8[H2J]-0+)1+JE+6ZX\53423(^SGPD>^->!0`"E`.P`````^``X:^?Q]/A
M"`&`2F`!*("`@(<0$![!`0'L$!#1!&?_`&AD'9/U/,\[4'?&-QAN':#D3$R2
M@BDP2D$R2=G@V#,RO`O!"+5FX8>7M45BFY>WXH:;+A_R5D:KQB^R>5?P'T\I
M[S"1:_\`B-1/VTX4[_F1VXD#PYD]PAQNTOMC]8=%`?YQQ9L8JB:RWX0L5LDE
M7*N0@\>=(7R-UDB<0^$P5H?O:X!^[M/3R?JE?J_^/THD(^]=52SIJ-/=S_'S
M']2&-MF=DQ5UMMTE1L_!H]RS7K:YJJBX]V5Z:71HF2V";<QA`%16@XUYP`/A
M,V,`=H<-2UHZ^FF'$9-J$^[F3\)'C$-O(IM75#3F"G$JY>,^5?P`^$:%]*,/
M,-6]+P#2DV]W:UR-*PSK,Z]L+M0Y4R-(1I&.G,H[,H;XJ8-F21S\P]A>7CK#
MU-IFVZTT[7:0O"5+M=SI':5T)P44/H+:N4F<E`*FDR,E`&+5#<W[-6-7>F(2
M_2N)=23D"@\PGPPQX1G;C=\=EF]F%WSC7*#<G6.Z9>8W'<M"+*,`3;STW'HO
M8]^K.I'$/-!NM(LFSMUX8KE%P^23!$>(G+^=2?[!O[@:=L?T53K6T#^BKKI7
MU>F_[_[MS8MBFY.EU^28!Z_3P)YI81]C_P#HC0SU$K72;)6'6+<D<O,WT.H1
M@OJ<W-R3E/ZOFQ'E@Z.UO+=,SEM_Q5DNAJ(%@9^H1!31R2W?*U^8CFJ<=/5I
MZ(\%"OH&7:K-E.8`$XI\X?%,`C^C]ETI;]"V:CT;:4%%IM=*U3,`XGHLH2VV
M2<)DH2"3M,X^)&].:C<7?7U!535+4XN7SUDE8[E$B)]UI01^2ZZ#5!9TZ62;
M-FR2B[APNH1%!!!$@J*K+*J"5-))),HF,8P@!0#B/9H`),AG'A(`F<HRV5'(
M.7]ZV8>I;=JW?\A3&"*Y@3-C.C4X]DGU:*Y>24,:N8](TK)GIH9)[,055D9-
M,I4><JRH'_"-Q%Y<:I[;3T32T(%474<QD.;.:L<\"0(^<M/U5WJK@\VMPT:6
M'.5,SRXB2<,L0DF/?TV.G#M+W@;;4,FY"5R"I?8V[6FIV5&N7-")CT/)ZC.1
M@Q)&C$/%&_?UZ6:G$PG'O#\PA]X.;S>*^WUG19Y.D4@B8GP.,]X,=6"PVRZT
M'O#_`%.L%E)DJ0PQ&$MQ$7^_P--CW[G,/_T-#_Q[63^)KG_M_H_XQM_@ZS_[
MOZ7^$1/?>F7TN\!6O'D9D;)5\HUJNDZS#'\/,Y-Y'UGEXV7B$4&T<S:UE59R
M/E62:(\/B@8ZP%`>(CPL,WJ]U3:U,H0I"1YB$Y"1X[IQ6>T]IVB=;34.+0XM
M7E!7F01EAO(AG;#_`'P>_7^09,_T9-HH:DNGY>I>U/T3$-E_--;V+^FF*5I^
M^T>_M@1G]'9;6E_+/\/ZQ&2/S>?WH?`8/EO[V+U/>QC-I%"_;U/*U*,\D<9W
MLZ*JB3%T[(D+ZNV`K4/&.:M.';)"MW7%=HNDFX1`3$,FJJVJZ.6Q_FES,*]I
M/K'$>G(PZWNS-7>G"9\M2C%"MV\'@?$&1'$:^/\`J';N-C[5EB7??M]OMSA:
MZ1.*@<UU3NGSJ6BF8`BV.]G50+3[J<C<A>5R9]'20E`/%(G6$QQV7;1;[F34
M6MY"5'$H.P]F:?`C<90OL7VZ6<"EO3"UH3@'$XS'$^RKMF#O$XF*=Z[VUXL:
M8*-C3.-SM"I0(PKJT#6(-)RY,`<B*LDE:9Q=,@G'@(HM'!_O$-\&JR=+UT_K
M5M)1OF3ZA\,6UZSMW+]2V\MS8)`>F9^`Q7RI;>-V75+S15,Q;N*K(X6VQ4AP
M+NHXK<I2,1(3\>LJW<.(J)B9(C6=.:RD02)+6%\BU.JU+W+!(I>`I7'*R@L=
M,JGMZ@[6JS5G+B2,,-B1/'.*+5#<]1U::JYI+-N0?*C$$C<`<<?E*,L,$C=+
M_6[K#U7'.T^*JM;D'3&%S(+=&.KD*\>-XJ,:5Y!LT2!K%M5B,6+=),J9.)2I
ME`H`'P:KZ:6.K4*6H3+>TYX\8MZN;)8IDM))`=R`R$N&0@[X?`'^8-*T.4?.
MB"`D=9;&UAKE<PAO1QN!&60MMF08,'LB"/>\:U,S3)S"+OR<Q0<Q\3=&S=$Z
M(B`'0EG`#V".F;3CR%K=MKV++R#AQ`Q\4S\!"AJNG<;;9NU/@_3K$SP)PGP"
MI=RC$G='G$4I5=N,[G2XE47R'NBO4WE.;D7/-XQ>O'?OV]9!7O`YP(_67?2A
M.T0$DD'WM0:AJ$N5@I6_L6$A([=OJ'=%G2U*IJ@56._;U*RLGAC+QQ/?'+ZE
M6R3)64[#0-V&UYSY.W)X6%BLC%ME&C1U=X.$>JRL26.7>&28+6:ON7#@J;=T
M8$)-BY5:',`@B4W5EN;+"%T%=C1N[?FDX'N.\9$3WQQJ"T5%2XBYV["X,RP^
M<`9B7$8X'`@D;HCK'O6QQC7HHE9W88DROA;+L(0K*R13.G.W\(^D&Y03<NX]
ME*.XNRPY7"H"8&KELJ5$!Y0<+``'&5[33ZU<]`XVY3G(SD?6#V@]T0,:NIVT
M].YM.LU(S'+,3X3D1V$=YB$<];T,Y]2F-=;9]D.(+U#XYN"J,=D[,UX9>08X
M:T=5,[N*7?,E7\77*^Z*01>AXIQ+22`"U0:E!13GM4MMI;,KWVYN)+R<4H3B
M9[]Y.[``9DQ4K;M67]/W?:&EAA>"W%8"6Z>(`WXDG(""]X-V=8JP]M:8[5WL
M6UN5,D*Y*Q>0EI1J5+SYF;00ZEKFW:29A.T4>O%1\(!#]XR110(13F1*?2]5
M7%^HKC7`\K@(*9?)`R'Q[\8:*.U4U+;1;2`MHI(5/Y1.9^+=AN@-S?$N]OI,
MWRSS>"ZS*[F=I-GDSS,I4FZ3Y_.P)``J8.I>/AVSR7KEI8L$B('F6+1Y&22*
M:9G:":A2%28_>+9?VDIJE!FX)$@=A[)X$<"01L,*@I;OIEY2Z))J+8HS*<21
MV@8@RPY@"#M`BQL-UWMK(QX!=,;9TI]D2*)7M?+7:M,$;N2E^.B20/;8E4Q0
M4#E`56R!ONB0/@U25I:NG]6MI2-\R/4?AB^C6=MY?KFWD.;I`^GF'P17#+N\
M[=QU)V3W`^S?!URQ[BFT<8B^Y4MAQCC/X!R)BO8^3M+9,U=J<"[:"(.VK!S)
MRS]'F13Y2'.F>Y3VZWV8BJN+J5OIQ2D8X[P,R=Q,@,XH55VNE_2:*U,K13*P
M4LX3&XJR2-X!*CE!B=E^T"D[/,'L<50RC>Q3<NJK-Y)MBS(B!KC9WS5)J\4!
MJ<51;P,>S2(S8M3&,";5/B;F545,9>N5P=N%47U8)&"1N'Q[3QAJM-K9M5&*
M9'F6<5J^<?B&0&[O@/;BK9^Z06?\A7B@8VL&8]E.6),)24C*V1P[D:+RN%UH
M]!V9!%T,#.U0KU5HV=NDPC9B-[M-59%RF`HL(<I-04B&G5ANY-B0)R5\8.9`
MQ!X9JQ;K=+USCS#:G;0Z9D#Y/Q%,Y`G!0V@Y6E?]='9VG"&=0U?S3-V4Z'\5
MJ"=*C6;Y5^)1`C%:26L9XM,.]^*8Z:BP]O$I3#V:HC3%QYI*+01OYO5*<:*M
M8VH(FE+I<^;RB<^V<HA[;'A[<#OOW=P&^C<O1'^+<38P3:GP3C2:1=MWS]Q'
M*KO*VX192+=E(K147)/#2SR4<-VX24D5!-LGX5$>[LUM126NWFUT2@Y4+]M0
MXY\)D8`;!.>,5;=2UUYNB;Q<$%NF;^S0>&6!QD#YB2!,RE@(^^QJN6./ZN.^
MJ9D*[8(^&D&.20CYE_"2C*(D!5R52%4@82CEHDP>BJDF8Y>Z4/S%*(AQ`!'7
MES6@V"E2%`J!3A,3]D[(+,VXG4]:M25!!"I&1D?.G(Y135.GW#_&A>3GF?;/
M(8[MXUZ$YYLSGD4605Z5*+P);P'DX6@&,`"KWG=@(\..M'J-_AOEYD\WN^4Q
M/,;,XR0T[^+2OD5R>]#&1ED=LI1K&TAQ],C\ED47"1T'"22Z"I1(JBLF55)0
M@_"4Z9P,0Y1^\(<-`)&(S@(!$CE'"CZ?4HEUXV+J]=C7G;_&X^$C&;KM'B/\
M8;MDU>T?\NNRXXH24I1':8C2TTDS2E(/`"'%KB)(6B"%H@AG7K(5$QA7EK;D
M:X5NC5=LY9LG%AM<PQ@H9!W(+E:L6RTC(KMVJ:SQR<$TRB8!.<0`.W4C3+KZ
M^FRE2E[@)F(GGV:9OJU"TH;GFH@#'+$P"#J-;A:KO:NF!MB6V2\1M_\`UAY%
MC)S*UIIKKRQ7(>!A2G51:FF6`JLI%.$8G=S3X$C*)("P:E,;O%.0K39Z-RV-
MNW2M24<B"$@X$D\..`':83+]7-7=UBS6]87SN`K*<0`.(SEBH]@WP?&JUF&I
M58KE.KC,D?7ZI!1-;@V*?#D9Q$(P;QL<U+P``$$&C8A>/#MX:57%J=6IQ>*U
M$D]IQAU;;0RVEIL20E(`'`"0@<67MVVX.MX(JE_Q11Z#>,F36]^[8`;T:94D
M82/MN/J)G3+-.=P<'+C+`E!Y)LU"QN#>,D'AE(I.?<IJ.4"M!.0G$=P_<.YK
M0WLUG.4SC&4H32$@+5CV*P]=+5C3SQ>0L=8L.8HR):(Z]TF7L$(Y)<8"TVF8
MA7\<9S&N(EVW%NY3\0V5*?I*UH]DD=ACA3:%^VD'M$X@F@[D=QT/TS4MV%DL
M^.9W(-OHF.;748.C8+FXZ`I!KA:(&M24:RHL?DR<F\BNVY9DZS%JB]CUG2Y"
M(@'%3B'A))F<3'0`2))$A$J2&>\V5#:;G++DE9I:9NU1<-&U4>7O:9D7#"L0
M#QU7HU1V7%<S<I*SY(;MC3)UT/`.FHO7"?A$^*@".O(]AOXYW39G[K>S#6.;
MA+PIMPP95,ITVX3>!,B[>9IU:+/6LQR[JN3V*K]9GM@L-,BBXZCEV=A9GCVD
MBN]?QZ8F7C5U0((;^WS==,9RR_@+#^5<98J@LPNL,9EG]R]:;0PS*L+D&AEV
MVO\`'MLQG,2R@O'.&\LUG+[^9AW#I)RX,D4K%95.0C9%$.PXXD22I0':8C4T
MTHS4E)/$"'#M^WW(Y9WBY=V[H36*?,$\5D-#;V-5=@XO#>=VX7&.QAGYEDE@
M6;<,1)+7&QMW]32:MV0N82,?+&%8`[Q/C/.)``!(91-&VV:W(3N4\^0N6,PX
M]NU5P[D)GC./B:MA!YCZ5F74MA_#N5&]E>SKC+5V21%@XR(\8"S39`19)!)7
MO"'$Y-$$1'6-R^=LQXIV.QE,DL>8\RANOH<WD&Z7Z6JTC:*Y2Z_2*=$V"RL*
M-1%K/$GF[989FR1[9B1_*&;,(\KYXJ1V9N1NJ00V;!EK.=3P?N?)5:MMYM6[
M';WGG&N$*?>)2F2-2Q;DV4RD;`5DITQ:HV,EG]BI$@O6<XMXR:!I)O$F<FT4
M?(%,V439D[+CA'*5*Y=TS$8::"N8)3S;Y"<2YMEWJM=P5\S81XQ846CXEPSA
M"X6>"L918WK%.3K!9]Q]8SICC*;@7ZL8UDL8RV&$&Q@1232$H*NTUG+1RU5U
MQ$D,;9/OM>[GJWGE>5D<:N;12XV'S)C^,HCQ5\DRP'EV&L,WAJ-OP*3,DH&4
MZ^I4I*.M*2`MD$GJ!!(BB54@:((E/[25\_PU/M?>`K/ZSOL-?:2\E^!D/,[S
M\_4'^L_P'DWRIY5\V?.'][[CQOB/"_%[_G_?-$$7DT00M$$+1!"T00M$$+1!
M`O>L+[#-\]&_2_&_I5]&>E\;_L_G_P#`?C.&MO3W_9HS]E66>1A=U3_TR_9]
MI&>7M#T[H&KT,_6;DCV=/1'_`(#U\_2#3Z%^H/Y0^<^'UM:G^P1]M[7^CO\`
M\V[A.%_1W[2Y]A[.S[3/9_EW\91ILTE1]"@2[OU<X`]$O>M95^'Y-[2&Y+Z/
M^M?\+\Y[[1!'6Z:OK1ZJ7J?]Y7D+U,_1'L_[=/37^MO]+/S]XK1!$,.O<=TW
MX/47B?U:_+_3ZI^KCZU?D3\Z=QH@AT5KV-=P/ML^F-`]O_TH])Z3Z&_53]U\
M_P";1!$W9Q]:V_3Z*]W+C7Y9\C^G=ZWI'\Q_@?Q7B-$$0#7?>F[1_4S[I+*O
MH_[0'KAV\?+OZHOR!^=_*>B"''BSU/\`1M]"/3IIZ+?3/L;;B?H7YS^E_P"/
M\1H@B[V`_6GO.^C/:.K7R#Y5[*^VSZ9_.7[GYIW.B"!+98]W9TU?2?TLQ#[+
M_M2>K&Z>R)]9/TA^H?EG1!$N;:O8'F?VTJUZT_7S[8>-/:O_`+R_Y0_$>3=$
M$0[?O6Y_^A?U.^S5MM]7'I/[.N:O:*_/W_,_4[PNB""!7?VTJAZ(>[XSM]"?
M^TL)>D'U*_('^MY4T00!IK[J^=][C[(53^5>SA[.MT^@_P"ZC^5?S#Y/T01_
"_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
